Migraine: Prevalence and associated disability among Nigerian undergraduates

Canadian Journal of Neurological Sciences

Volumn 36, Issue 2, 2009, Pages 216-221

  Wahab, Kolawole Wasiu ^a   Ugheoke, Asuwemhe Johnson ^b  

^a UNIVERSITY OF ILORIN   (Nigeria)

^b IRRUA SPECIALIST TEACHING HOSPITAL   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CAFERGOT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; SEDATIVE AGENT; TRIPTAN DERIVATIVE; ANALGESIC AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; DISABILITY; DISEASE SEVERITY; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; NIGERIA; PAIN ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; UNIVERSITY STUDENT; CROSS-SECTIONAL STUDY; STUDENT;

ADULT; ANALGESICS; CROSS-SECTIONAL STUDIES; DISABILITY EVALUATION; FEMALE; HUMANS; MALE; MIGRAINE DISORDERS; NIGERIA; PREVALENCE; STUDENTS;

EID: 65649103756     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100006570     Document Type: Article

References (22)

1. Menken M, Munsat TL, Toole JF. The global burden of disease study implications for neurology. Arch Neurol. 2000; 57: 418-420.
2. Osuntokun BO, Adeuja AO, Nottidge VA, Bademosi O, Alumide AO, Ige O, et al. Prevalence of headache and migrainous headache among Nigerian Africans: a community-based study. EastAfrMed J. 1992; 69(4): 196-199.
3. Stewart WF, Lipton RB, Celentano DD, Reed MI. Prevalence of migraine headache in the United States: relation to age, income, race and other sociodemographic factors. JAMA. 1992; 267: 64-69.
4. Rasmussen BK, Olesen J. Symptomatic and nonsymptomatic headaches in a general population. Neurology. 1992; 42: 1225-1231.
5. Steiner TJ, Stewart WF, Kolodner K, Liberman J, Lipton RB. Epidemiology of migraine in England. Cephalalgia. 1999; 19: 3305-3306 [abstract].
6. Pryse-Phillips W, Findlay H, Tugwell P, Edmeads J, Murray TJ, Nelson RF. A Canadian population survey on the clinical, epidemiologic and societal impact of migraine and tension-type headache. Can J Neurol Sci. 1992; 19 (3): 333-339.
7. Mitsikostas DD, Gatzonis S, Thomas A, Kalfakis N, Ilias A, Papageoergiou C. An epidemiological study of headaches among medical students in Athens. Headache. 1996; 36: 561-564.
8. Sanvito WL, Monzillo PH, Peres MF, Martinelli MO, Fera MP, Gouveia DA, et al. The epidemiology of migraine in medical students. Headache. 1996; 36: 316-319.
9. Lipton RB, Stewart WF, Stone AM, Lainez MJA, Sawyer JPC. Stratified care versus step care strategies for migraine. JAMA. 2000; 284: 2599-2605.
10. Lipton RB, Silberstein SD. The role of headache-related disability in migraine management: implications for headache treatment guidelines. Neurology. 2001; 56: 35-42.
11. Oluwole S,BwalaSA,Nwabueze AC, DaviesAO. Effectiveness of sumatriptan for acute treatment of migraine headache in an African population. Afr J Neurol Sci. 2003; 22(2). Available from: http://www.ajol.info. [cited 2008 Jan 7].
12. World Health Organization Teaching Statistics. In: Lwanga SK,Tye CY, editors. Twenty lessons and seminar outlines. Geneva WHO. 1986. p. 67-74.
13. Ogunyemi AO. Prevalence of headache among Nigerian university students. Headache. 1984; 24: 127-130.
14. Headache Classification Committee of the International Headache Society. The international classification of headache disorders. (2nd ed.). Cephalalgia. 2004; 24 suppl 1: 1-160.
15. Stewart WF, Lipton RB, Kolodner K, Liberman J, Sawyer J. Reliability of the Migraine Disability Assessment score in a population-based sample of headache sufferers. Cephalalgia. 1999; 19: 107-114. (Pubitemid 29170106)
16. Bener A. Frequency of headache and migraine in Qatar. Neuroepidemiology. 2006; 27(2): 61-66.
17. Deleu D, Khan MA, Humaidan H, Al Mantheri Z, Al Hashami S. Prevalence and clinical characteristics of headache in medical students in Oman. Headache. 2001; 41 (8): 798-804.
18. Demirkirkan MK, Ellidokuz H, Boluk A. Prevalence and clinical characteristics of migraine in university students in Turkey. Tohoku J Exp Med. 2006; 208: 87-92.
19. O'Brien B, Goeree R, Streiner D. Prevalence of migraine headache in Canada: a population-based survey. Int J Epidemiol. 1994; 23 (5): 1020-1026.
20. Ad Hoc Committee: Classification of Headache. JAMA. 1962; 179: 717-718.
21. MacGregor EA, Brandes J, Eikermann A. Migraine prevalence and treatment patterns: the global migraine and zolmitriptan evaluation survey. Headache. 2003; 43: 19-26.
22. Jelinski SE, Becker WJ, Christie SN, Giammarco R, Mackie GF, Gawel MJ, et al. Clinical features and pharmacological treatment of migraine patients referred to headache specialists in Canada. Cephalalgia. 2005; 26: 578-88.